Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT07008066
Starting soon Not applicable

Exercise-induced Cardioversion in Persistent Atrial Fibrillation

NCT07008066 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-06-06

Condition(s) studied

Atrial Fibrillation (AF)

Investigational drug(s) / intervention(s)

Bicycle ergometer excerciseStandard care with electrical cardioversion

Bicycle ergometer excercise: Patients will undergo a symptom-limited ergometer cycling test under medical supervision. If the atrial fibrillation is not converted to sinus rhythm during the exercise test, the patients will be electrically converted.

Standard care with electrical cardioversion: Standard care with planned electrical cardioversion without exercise intervention.

Study summary

This study aims to to evaluate the feasibility of conducting a larger randomized controlled trial (RCT) to assess whether an exercise stress test on an ergometer bicycle could induce sinus rhythm in patients with persistent AF scheduled for electrical cardioversion and if this intervention (regardless of rhythm conversion) could improve health-related quality of life in these patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Adults (18-75 years) with persistent AF * planned for EC * with at least 3 weeks of therapeutic oral anticoagulation before intervention Exclusion Criteria: * Unable to perform a symptom limited cycle exercise test * Ischemic heart disease * Heart failure * Severe valvular disease * Unable to speak and write Swedish language * Unable to provide written, informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre for Clinical Research, Uppsala University, Västmanland County Hospital Västerås Sweden

More Uppsala University trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07008066 on ClinicalTrials.gov ↗ ← All trials in Sweden